Hase Ryota, Uwamino Yoshifumi, Muranaka Kiyoharu, Tochitani Kentaro, Sogi Misa, Kitazono Hidetaka, Hosokawa Naoto
Department of General Medicine and Infectious Diseases, Kameda Medical Center.
Kansenshogaku Zasshi. 2013 Jul;87(4):446-50. doi: 10.11150/kansenshogakuzasshi.87.446.
We report herein on a case of Plasmodium malariae malaria with more than a 4-month incubation period. A 35-year-old Japanese man who first presented to our clinic with fever and history of travel to Papua New Guinea was suspected of having Plasmodium vivax malaria based on peripheral smear results. We admitted him and initiated treatment with mefloquine. After two days of therapy, he became afebrile. We discharged him, and P. vivax was later confirmed with PCR. We started mefloquine prophylaxis for a planned trip to Papua New Guinea. After his return, a standard dose of primaquine (15 mg x 14 days) was prescribed for a radical cure of P. vivax. About 4 months after his last visit to Papua New Guinea, he returned to our clinic with fever. We suspected a relapse of P. vivax malaria and admitted him for a second time. After two days of mefloquine therapy, his symptoms improved. We discharged him and restarted a higher dose of primaquine (30 mg x 14 days) therapy for a radical cure of P. vivax. Subsequently, the PCR test revealed the parasite was P. malariae and not P. vivax. Only 13 cases of Plasmodium malariae malaria have been reported in Japan during the past 10 years. Blood-stage schizonticides such as mefloquine is not active against the liver stage. Therefore, the use of these drugs for prophylaxis will not be effective for prevention of malaria if its liver stage is longer than the duration of effective chemoprophylaxis. Although the incubation period of P. malariae is typically 13 to 28 days, it occasionally lasts for months or even years. Careful attention should be given to the possibility that P. malariae occasionally has a long incubation period even in the absence of the hypnozoite stage.
我们在此报告一例潜伏期超过4个月的间日疟原虫疟疾病例。一名35岁的日本男子首次因发热到我们诊所就诊,有前往巴布亚新几内亚的旅行史,根据外周血涂片结果怀疑患有间日疟原虫疟疾。我们收治了他并开始用甲氟喹进行治疗。治疗两天后,他退热了。我们让他出院,后来通过聚合酶链反应(PCR)确诊为间日疟原虫。我们开始用甲氟喹预防计划前往巴布亚新几内亚的旅行。他回来后,为彻底治愈间日疟原虫,给他开了标准剂量的伯氨喹(15毫克×14天)。在他最后一次访问巴布亚新几内亚约4个月后,他因发热回到我们诊所。我们怀疑是间日疟原虫疟疾复发,再次收治了他。甲氟喹治疗两天后,他的症状有所改善。我们让他出院,并重新开始用更高剂量的伯氨喹(30毫克×14天)治疗以彻底治愈间日疟原虫。随后,PCR检测显示寄生虫是三日疟原虫而非间日疟原虫。在过去10年中,日本仅报告了13例三日疟原虫疟疾病例。像甲氟喹这样的血液期裂殖体杀灭剂对肝脏期无效。因此,如果疟疾的肝脏期长于有效化学预防的持续时间,使用这些药物进行预防对预防疟疾将无效。虽然三日疟原虫的潜伏期通常为13至28天,但偶尔会持续数月甚至数年。即使在没有休眠子阶段的情况下,也应仔细关注三日疟原虫偶尔有长潜伏期的可能性。